weren't Dr. Bridges and Tim Hughes seat on this Board from day 1? While the "new" FTT board did apparently run a good (AND expensive) trial, why did they not do greater due diligence on the product and related science before embarking on that "very expensive, well-run" trial. Why after the millions of dollars handed over to QUT for research over the TIS years, didn't any of the "researchers" twig that it was not very effective? Surely someone must have. I mean us retail shareholders had nothing to go on but Pro Harding and those pictures of ulcers healing at phenomenal rates - we assumed the Board had access to significantly more information and details to confirm the product was effective and warranted the huge investment and risk inherent in the trial. I had assumed that CB, as a serial (or is that cereal?) biotech "entrepreneur" would have studied all this with a fine tooth comb before jumping on board....
FTT Price at posting:
0.4¢ Sentiment: None Disclosure: Held
